Organon & Co | OGN - 销售收入





销售 更改 日
Bristol-Myers Squibb USD 11.49B 1.01B 2026-03
Celltrion KRW 1.15T 180B 2026-03
Cspc Pharmaceutical CNY 6.47B 355.1M 2026-03
Deva Holding AS TRY 2.32B 418.58M 2023-09
Dianthus Therapeutics USD 463K 179K 2026-03
Divis Laboratories Ltd INR 28.31B 2.27B 2026-03
Gilead Sciences USD 7B 930M 2026-03
Glaxosmithkline GBP 10.09B 1.37B 2026-03
Kangmei Pharma CNY 1.08B 288.27M 2026-03
Knight Therapeutics CAD 133.11M 11.56M 2025-12
Laboratorios Farma EUR 448.66M 67.82M 2023-12
Medical Developments International AUD 21.57M 12.04M 2025-12
Merck USD 16.29B 110M 2026-03
Neuren Pharmaceuticals AUD 42.24M 28.1M 2025-12
Novartis USD 13.11B 750M 2026-03
Organigram Holdings CAD 59.79M 3.74M 2026-03
Organon & Co USD 1.46B 50M 2026-03
Pharma Mar EUR 42.9M 47.3M 2026-03
Qiagen NV USD 419.22M 38.16M 2026-03
Sartorius EUR 899.1M 28.5M 2026-03
Sino Biopharmaceutical CNY 14.26B 3.31B 2025-12
Tilray USD 217.51M 74.75M 2025-12
Zealand Pharma A/S 68.91M 19.35M 2025-12